Prevalence and Associated Factors of Low-Level Viremia in Chronic Hepatitis B Patients After Long-Term Therapy with Nucleos(t)ide Analogs.

Jiajia Han,Yifei Guo,Xueyun Zhang,Yao Zhang,Jian Sun,Jingjing He,Richeng Mao,Yuxian Huang,Jiming Zhang

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology（2023）

引用 0|浏览19

暂无评分

摘要

Having received long-term antiviral treatment, low-level viremia still occurred in 31.9% of patients. Longer duration of therapy was a protective factor, and HBeAg-positivity and entecavir treatment were risk factors for low-level viremia.

查看译文

关键词

Antiviral agents,chronic,hepatitis B,risk factors,viremia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要